Full data view for gene ELAC2

Information The variants shown are described using the NM_018127.6 transcript reference sequence.

61 entries on 1 page. Showing entries 1 - 61.
Legend   How to query  

Effect     

Exon     

AscendingDNA change (cDNA)     

RNA change     

Protein     

Allele     

Type     

DNA change (genomic) (hg19)     

Reference     

DB-ID     

Frequency     

Variant remarks     

ClassClinical     

Template     

Technique     

Disease     

Reference     

Remarks     

Gender     

Age     

α-thal genotype     

β-thal genotype     

Panel size     

Owner     
./. 01 c.35C>T - p.Ala12Val Unknown Substitution - GenBank ELAC2_00049 NA - - - - - - - - - - - - -
./. 01 c.94C>G - p.Pro32Ala Unknown Substitution - GenBank ELAC2_00048 NA - - - - - - - - - - - - -
./. 01 c.155C>T - p.Ser52Phe Unknown Substitution - GenBank ELAC2_00047 NA - - - - - - - - - - - - -
./. 01 c.224A>G - p.Tyr75Cys Unknown Substitution - GenBank ELAC2_00046 NA - - - - - - - - - - - - -
./. 03 c.308C>T - p.Ala103Val Unknown Substitution - GenBank ELAC2_00045 NA - - - - - - - - - - - - -
./. 03 c.347C>T - p.Ser116Phe Unknown Substitution - GenBank ELAC2_00044 NA - - - - - - - - - - - - -
./. 04 c.368-4T>A - - Unknown Substitution - GenBank ELAC2_00054 - - - - - - - - - - - - - -
./. 04 c.387G>A - p.Lys129Lys Unknown Substitution - GenBank ELAC2_00004 - - - - - - - - - - - - - -
./. 06 c.491-37_491-53dup - - Unknown Duplication - GenBank ELAC2_00051 - - - - - - - - - - - - - -
./. 06 c.491-14T>C - - Unknown Substitution - GenBank ELAC2_00050 - - - - - - - - - - - - - -
./. 06 c.512C>T - p.Pro171Leu Unknown Substitution - GenBank ELAC2_00043 NA - - - - - - - - - - - - -
./. 07 c.632G>A - p. Arg211Gln Unknown Substitution - GenBank ELAC2_00006 1/3 - - - - - - - - - - - - -
./. 07 c.632G>A - p.Arg211Gln Unknown Substitution - GenBank ELAC2_00006 NA - - - - - - - - - - - - -
./. 07 c.646G>T - p.Glu216X Unknown Substitution - GenBank ELAC2_00005 2/3 This alteration was not present in the one female available for study - - - - - - - - - - - -
./. 07 c.650C>T - p.Ser217Leu Unknown Substitution - GenBank ELAC2_00001 - Leu217 results are more often significant in the most extreme (FAM vs. LOW) case/control comparison and are never significant in the broadest (ALL vs. ALL) comparison. - - - - - - - - - - - -
./. 07 c.650C>T - p.Ser217Leu Unknown Substitution - GenBank ELAC2_00001 - The Leu217 homozygous frequencies were similar in cases and controls, indicating that this variant does not act in a recessive manner as previously suggested - - - - - - - - - - - -
./. 07 c.650C>T - p.Ser217Leu Unknown Substitution - GenBank ELAC2_00001 - the missense mutations do not affect the enzyme/substrate complex formation, the chemical cleavage step, and the substrate release process.tRNase ZL variants show the same level of the RNase 65 activity as the wild type.there is no causality between the enzymatic properties of tRNase ZL and the prostate cancer. - - - - - - - - - - - -
./. 07 c.650C>T - p.Ser217Leu Unknown Substitution - GenBank ELAC2_00001 - Substitution of Ser217 with a bulky hydrophobic residue may result in structural consequences to the protein. - - - - - - - - - - - -
./. 07 c.650C>T - p.Ser217Leu Unknown Substitution - GenBank ELAC2_00001 - The probability of having CaP was increased in men who carried the Leu217/Thr541 variants - - - - - - - - - - - -
./. 07 c.650C>T - p.Ser217Leu Unknown Substitution - GenBank ELAC2_00001 3.3% - - - - - - - - - - - - -
./. 07 c.650C>T - p.Ser217Leu Unknown Substitution - GenBank ELAC2_00001 - the mutation is rare in HPC and that the variant Leu217 do not appear to influence the risk for HPC - - - - - - - - - - - -
./. 07 c.650C>T - p.Ser217Leu Unknown Substitution - GenBank ELAC2_00001 - - - - - - - - - - - - - -
./. 07 c.650C>T - p.Ser217Leu Unknown Substitution - GenBank ELAC2_00001 - - - - - - - - - - - - - -
./. 07 c.679+59T>C - - Unknown Substitution - GenBank ELAC2_00052 - - - - - - - - - - - - - -
./. 08 c.700G>A - p.Val234Ile Unknown Substitution - GenBank ELAC2_00042 NA - - - - - - - - - - - - -
./. 10 c.809C>T - p.Ala270Val Unknown Substitution - GenBank ELAC2_00041 NA - - - - - - - - - - - - -
./. 10 c.841G>A - p.Gly281Arg Unknown Substitution - GenBank ELAC2_00040 NA - - - - - - - - - - - - -
./. 13 c.1186A>G - p.Ile396Val Unknown Substitution - GenBank ELAC2_00039 NA - - - - - - - - - - - - -
./. 14 c.1237A>C - p.Ser413Arg Unknown Substitution - GenBank ELAC2_00038 NA - - - - - - - - - - - - -
./. 15 c.1306G>A - p.Asp436Asn Unknown Substitution - GenBank ELAC2_00037 NA - - - - - - - - - - - - -
./. 15 c.1315A>G - p.Ile439Val Unknown Substitution - GenBank ELAC2_00036 NA - - - - - - - - - - - - -
./. 15 c.1342G>A - p.Val448Ile Unknown Substitution - GenBank ELAC2_00035 NA - - - - - - - - - - - - -
./. 15 c.1400C>T - p.Ala467Val Unknown Substitution - GenBank ELAC2_00034 NA - - - - - - - - - - - - -
./. 16 c.1435C>T - p.Gln479Ter Unknown Substitution - GenBank ELAC2_00033 NA - - - - - - - - - - - - -
./. 16 c.1460G>A - p.Gly487Glu Unknown Substitution - GenBank ELAC2_00007 - - - - - - - - - - - - - -
./. 16 c.1468T>G - p.Ser490Ala Unknown Substitution - GenBank ELAC2_00032 NA - - - - - - - - - - - - -
./. 17 c.1525G>A - p.Asp509Asn Unknown Substitution - GenBank ELAC2_00031 NA - - - - - - - - - - - - -
./. 17 c.1562T>C - p.Phe521Ser Unknown Substitution - GenBank ELAC2_00030 NA - - - - - - - - - - - - -
./. 17 c.1574G>T - p.Cys525Phe Unknown Substitution - GenBank ELAC2_00029 NA - - - - - - - - - - - - -
./. 17 c.1621G>A - p.Ala541Thr Unknown Substitution - GenBank ELAC2_00002 - Is significantly associated with prostate cancer. - - - - - - - - - - - -
./. 17 c.1621G>A - p.Ala541Thr Unknown Substitution - GenBank ELAC2_00002 - The Thr541 allele showed linkage disequilibrium and was only detected in the presence of the Leu217 allele.The proportion of control Thr541 carriers decreased with age but was not significant - - - - - - - - - - - -
./. 17 c.1621G>A - p.Ala541Thr Unknown Substitution - GenBank ELAC2_00002 - the missense mutations do not affect the enzyme/substrate complex formation, the chemical cleavage step, and the substrate release process.tRNase ZL variants show the same level of the RNase 65 activity as the wild type.there is no causality between the enzymatic properties of tRNase ZL and the prostate cancer. - - - - - - - - - - - -
./. 17 c.1621G>A - p.Ala541Thr Unknown Substitution - GenBank ELAC2_00002 - May have bearing on the predicted enzymatic activity of the protein. - - - - - - - - - - - -
./. 17 c.1621G>A - p.Ala541Thr Unknown Substitution - GenBank ELAC2_00002 - the presence of a Thr541 allele may have deleterious effects on the function of the protein encoded by this gene - - - - - - - - - - - -
./. 17 c.1621G>A - p.Ala541Thr Unknown Substitution - GenBank ELAC2_00002 0.8% - - - - - - - - - - - - -
./. 17 c.1621G>A - p.Ala541Thr Unknown Substitution - GenBank ELAC2_00002 - the mutation is rare in HPC and that the variant Thr541 do not appear to influence the risk for HPC - - - - - - - - - - - -
./. 17 c.1621G>A - p.Ala541Thr Unknown Substitution - GenBank ELAC2_00002 - - - - - - - - - - - - - -
./. 17 c.1621G>A - p.Ala541Thr Unknown Substitution - GenBank ELAC2_00002 - - - - - - - - - - - - - -
./. 17 c.1641dup - p.His548AlafsX68 Unknown Duplication - GenBank ELAC2_00053 - - - - - - - - - - - - - -
./. 19 c.1723C>T - p.Pro575Ser Unknown Substitution - GenBank ELAC2_00028 NA - - - - - - - - - - - - -
./. 20 c.1880C>T - p.Ser627Leu Unknown Substitution - GenBank ELAC2_00027 A=0.004/4 - - - - - - - - - - - - -
./. 20 c.1893A>G - p.Thr631Thr Unknown Substitution - GenBank ELAC2_00009 - - - - - - - - - - - - - -
./. 21 c.1924G>A - p.Val642Met Unknown Substitution - GenBank ELAC2_00026 NA - - - - - - - - - - - - -
./. 22 c.2054A>C - p.His685Pro Unknown Substitution - GenBank ELAC2_00025 NA - - - - - - - - - - - - -
./. 03 c.2243A>C - p.Asp748Ala Unknown Substitution - GenBank ELAC2_00024 NA - - - - - - - - - - - - -
./. 24 c.2342G>A - p.Arg781His Unknown Substitution - GenBank ELAC2_00003 - the missense mutations do not affect the enzyme/substrate complex formation, the chemical cleavage step, and the substrate release process.tRNase ZL variants show the same level of the RNase 65 activity as the wild type.there is no causality between the enzymatic properties of tRNase ZL and the prostate cancer. - - - - - - - - - - - -
./. 24 c.2342G>A - p.Arg781His Unknown Substitution - GenBank ELAC2_00003 - His781 contributes to the phenotype conferred by the triple missense allele. - - - - - - - - - - - -
./. 24 c.2342G>A - p.Arg781His Unknown Substitution - GenBank ELAC2_00003 - - - - - - - - - - - - - -
./. 24 c.2372G>A - p.Arg791Gln Unknown Substitution - GenBank ELAC2_00023 NA - - - - - - - - - - - - -
./. 24 c.2404G>A - p.Gly802Ser Unknown Substitution - GenBank ELAC2_00022 NA - - - - - - - - - - - - -
./. 24 c.2417G>A - p.Gly806Arg Unknown Substitution - GenBank ELAC2_00008 2/2 - - - - - - - - - - - - -
Legend   How to query